| Product Code: ETC10765509 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Pemetrexed Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 China Pemetrexed Market - Industry Life Cycle |
3.4 China Pemetrexed Market - Porter's Five Forces |
3.5 China Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 China Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 China Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 China Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 China Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 China Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of lung cancer in China |
4.2.2 Growing awareness about the benefits of pemetrexed in cancer treatment |
4.2.3 Rising healthcare expenditure and investments in oncology research and development in China |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in China |
4.3.2 Competition from alternative cancer treatment therapies |
4.3.3 High cost associated with pemetrexed treatment in China |
5 China Pemetrexed Market Trends |
6 China Pemetrexed Market, By Types |
6.1 China Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 China Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 China Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 China Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 China Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 China Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 China Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 China Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 China Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 China Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 China Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 China Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 China Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 China Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 China Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 China Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 China Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 China Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 China Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 China Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 China Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 China Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 China Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 China Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 China Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 China Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 China Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 China Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 China Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 China Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 China Pemetrexed Market Import-Export Trade Statistics |
7.1 China Pemetrexed Market Export to Major Countries |
7.2 China Pemetrexed Market Imports from Major Countries |
8 China Pemetrexed Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on pemetrexed in China |
8.2 Adoption rate of pemetrexed in cancer treatment centers and hospitals |
8.3 Number of partnerships and collaborations between pharmaceutical companies and healthcare institutions for pemetrexed research and development |
9 China Pemetrexed Market - Opportunity Assessment |
9.1 China Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 China Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 China Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 China Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 China Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 China Pemetrexed Market - Competitive Landscape |
10.1 China Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 China Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here